This is not the most recent version of the article. View current version (21 JAN 2009)

Intervention Protocol

Aldose reductase inhibitors for the treatment of diabetic polyneuropathy

  1. C Chalk,
  2. TJ Benstead,
  3. F Moore

Editorial Group: Cochrane Neuromuscular Disease Group

Published Online: 18 JUL 2007

DOI: 10.1002/14651858.CD004572

Database Title

Additional Information

How to Cite

Chalk C, Benstead TJ, Moore F. Aldose reductase inhibitors for the treatment of diabetic polyneuropathy (Protocol). Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD004572. DOI: 10.1002/14651858.CD004572.

Author Information

*Dr Colin Chalk, Dept. of Neurology and Neurosurgery, McGill University, Montreal General Hospital - Room L7313, 1650 Cedar Avenue, Montreal, Quebec, H3G 1A4, CANADA. colin.chalk@staff.mcgill.ca.

Publication History

  1. Published Online: 18 JUL 2007

SEARCH

ARTICLE TOOLS

This is not the most recent version of the article.View current version (21 Jan 2009)

View Full Article (HTML) Full (110K)
 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The objective of this review is to assess the effects of aldose reductase inhibitors on the progression of symptoms, signs, or functional disability in diabetic polyneuropathy.

View Full Article (HTML) Full (110K)